ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
ViiV and Janssen seek European approval for HIV two-drug regimen pharmaceutical-technology
July 31, 2019ViiV Healthcare and Janssen Pharmaceutical have filed separate marketing authorisation applications (MAA) for the use of their respective drugs, cabotegravir and rilpivirine, as a combination therapy in adults with HIV infection.
Pharma Sources Insight January 2025
